8532 related articles for article (PubMed ID: 10894142)
1. Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy.
Corsetti RL; Allen HM; Wanebo HJ
Ann Surg Oncol; 2000 Jul; 7(6):456-60. PubMed ID: 10894142
[TBL] [Abstract][Full Text] [Related]
2. Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma.
Jacobs IA; Chang CK; DasGupta TK; Salti GI
Ann Surg Oncol; 2003 Jun; 10(5):558-61. PubMed ID: 12794023
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in patients with thin melanomas.
Cecchi R; Buralli L; Innocenti S; De Gaudio C
J Dermatol; 2007 Aug; 34(8):512-5. PubMed ID: 17683380
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
6. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
7. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.
Mitteldorf C; Bertsch HP; Jung K; Thoms KM; Schön MP; Tronnier M; Kretschmer L
Ann Surg Oncol; 2014 Jul; 21(7):2252-8. PubMed ID: 24652352
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy for thin melanomas: which patients should be considered?
Puleo CA; Messina JL; Riker AI; Glass LF; Nelson C; Cruse CW; Johnson TM; Sondak VK
Cancer Control; 2005 Oct; 12(4):230-5. PubMed ID: 16258494
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.
Hinz T; Ahmadzadehfar H; Wierzbicki A; Höller T; Wenzel J; Biersack HJ; Bieber T; Schmid-Wendtner MH
Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):581-8. PubMed ID: 22160198
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node.
Mori M; Sugiura M; Kono M; Matsumoto T; Sawada M; Yokota K; Yasue S; Shibata S; Sakakibara A; Nakamura S; Tomita Y; Akiyama M
J Cutan Pathol; 2013 Dec; 40(12):1027-34. PubMed ID: 24111935
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
14. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
Bartlett EK; Gimotty PA; Sinnamon AJ; Wachtel H; Roses RE; Schuchter L; Xu X; Elder DE; Ming M; Elenitsas R; Guerry D; Kelz RR; Czerniecki BJ; Fraker DL; Karakousis GC
Ann Surg Oncol; 2014 Feb; 21(2):643-9. PubMed ID: 24121883
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy for melanoma: an update after two decades of experience.
Ross MI
Semin Cutan Med Surg; 2010 Dec; 29(4):238-48. PubMed ID: 21277537
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
17. Results of sentinel lymph node biopsy in patients with thin melanoma.
Wong SL; Brady MS; Busam KJ; Coit DG
Ann Surg Oncol; 2006 Mar; 13(3):302-9. PubMed ID: 16485151
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
19. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
20. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]